HopeStage
Back to all studies
CompletedNCT00341029

Genetic Measurements in Blood Cells of Children Taking Adderall or Methylphenidate

Observational studyAges 6–12United StatesADHD
The study in practice

Understand this study

Who was this study for?

Listed age limits: 6 years to 12 years.

Listed locations
Durham, United StatesSee all locations and recruitment
Compensation
Payment and expense reimbursement have not been verified.
Study clarity

Study information

Study start dateDecember 7, 2005
Recruitment status
Completed
Enrollment listed in the registry
84
Sponsor
National Institute of Environmental Health Sciences (NIEHS)
Sponsor type
Research institute
Study type
Observational
Intervention type
Interview / survey / observational
Study phase
Not clearly listed
Locations
United States
Age range
From 6 Years to 12 Years
Official registry ID
NCT00341029
Official title
Show the full official title

Measurement of Cytogenetic Endpoints in Lymphocytes of Children Diagnosed With Attention Deficit/Hyperactivity Disorder (ADHD) and Treated With Methylphenidate or Adderall

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Durham

FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute of Environmental Health Sciences (NIEHS), a research institute.

Who was this study for?

Listed age limits: 6 years to 12 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me